Technical Analysis for ATRS - Antares Pharma, Inc.

Grade Last Price % Change Price Change
D 4.13 1.72% 0.07
ATRS closed up 1.72 percent on Thursday, April 15, 2021, on 41 percent of normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Flat
Historical ATRS trend table...

Date Alert Name Type % Chg
Crossed Above 20 DMA Bullish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
20 DMA Resistance Bearish 1.72%
Pocket Pivot Bullish Swing Setup 1.72%
Bollinger Band Squeeze Range Contraction 1.72%
Outside Day Range Expansion 1.72%
Bollinger Band Squeeze Range Contraction 2.23%
Down 3 Days in a Row Weakness 2.23%
Bollinger Band Squeeze Range Contraction 1.47%
Older End-of-Day Signals for ATRS ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
20 DMA Resistance about 18 hours ago
10 DMA Resistance about 18 hours ago
Rose Above 20 DMA about 19 hours ago
Rose Above 10 DMA about 19 hours ago
Up 2% about 19 hours ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Antares Pharma, Inc. Description

Antares Pharma, Inc. operates as a specialty pharmaceutical company that focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies, and topical gel-based medicines worldwide. The company's products include Tjet/Zomajet, the needle-free auto injectors to deliver human growth hormone treatment to children without the use of a needle; twin-jector EZ II needle free injectors; Medi-Jet auto injectors; Elestrin, an estrogen replacement gel for the treatment of hot flashes; and Gelnique 3%, an oxybutynin gel product for the treatment of overactive bladder. The company is also developing OTREXUP, a product for the delivery of methotrexate using Medi-Jet technology for the treatment of rheumatoid arthritis, poly-articular-course juvenile rheumatoid arthritis, and psoriasis; and VIBEX QS T, an auto injector for the treatment of testosterone deficiency or replacement therapy. In addition, it is developing Vibex auto injectors; disposable pen injectors; and Nestragel, a contraceptive gel. Antares Pharma, Inc. has collaborative and license agreements with Ferring Pharmaceuticals BV; Teva Pharmaceutical Industries, Ltd.; JCR Pharmaceuticals Co., Ltd.; Actavis, Inc.; Daewoong Pharmaceuticals; BioSante Pharmaceuticals, Inc.; Meda Pharmaceuticals; Population Council; and Pfizer Inc. The company was founded in 1979 and is headquartered in Ewing, New Jersey.


Classification

Sector: Healthcare
Industry: Medical Instruments & Supplies
Keywords: Biotechnology Pharmaceutical Pharmaceutical Products Medical Equipment Pharmacology Flash Rheumatoid Arthritis Psoriasis Pharmaceutical Industries Injector Estrogen Growth Hormone Testosterone Hot Flash Teva Pharmaceutical Industries Methotrexate Overactive Bladder Testosterone Deficiency

Is ATRS a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 5.06
52 Week Low 2.39
Average Volume 1,221,316
200-Day Moving Average 3.46
50-Day Moving Average 4.32
20-Day Moving Average 4.12
10-Day Moving Average 4.11
Average True Range 0.15
ADX 16.15
+DI 14.39
-DI 16.34
Chandelier Exit (Long, 3 ATRs ) 4.03
Chandelier Exit (Short, 3 ATRs ) 4.34
Upper Bollinger Band 4.30
Lower Bollinger Band 3.93
Percent B (%b) 0.54
BandWidth 8.85
MACD Line -0.05
MACD Signal Line -0.06
MACD Histogram 0.0072
Fundamentals Value
Market Cap 688.36 Million
Num Shares 167 Million
EPS 0.06
Price-to-Earnings (P/E) Ratio 72.46
Price-to-Sales 3.83
Price-to-Book 8.33
PEG Ratio -0.26
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.24
Resistance 3 (R3) 4.24 4.20 4.22
Resistance 2 (R2) 4.20 4.18 4.20 4.21
Resistance 1 (R1) 4.17 4.16 4.19 4.17 4.21
Pivot Point 4.13 4.13 4.14 4.13 4.13
Support 1 (S1) 4.10 4.11 4.11 4.09 4.05
Support 2 (S2) 4.06 4.09 4.06 4.05
Support 3 (S3) 4.03 4.06 4.04
Support 4 (S4) 4.02